(WASHINGTON) -- The Food and Drug Administration has authorized a new monoclonal antibody treatment for COVID-19, shown to hold up against the omicron variant and BA.2 subvariant. The drug, called bebtelovimab from Eli Lilly, is a monoclonal therapy meant for COVID-19 patients as young as... Read More.
(NEW YORK) -- Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within a month of getting the shot. In a lab study, the company gave 20 fully vaccinated participants a 50-microgram booster -- the current dose authorized by... Read More.
(NEW YORK) -- In the midst of a delta variant surge, a new study finds that giving a booster dose of the Johnson & Johnson shot six months after primary vaccination results in a nine-fold increase of a crucial antibody response, according to a... Read More.
(NEW YORK) -- The use of monoclonal antibodies as a way to prevent people from getting very sick with COVID-19 is rapidly increasing -- alongside the grim statistics on surging infection rates across the country. Federal health officials have seen a "significant increase" in the... Read More.
(JACKSONVILLE, Fla.) -- The city of Jacksonville scrambled this week to increase the number of wheelchairs at state-run sites providing Regeneron's monoclonal antibody treatment for COVID-19, after an influx of patients came in need of care. The city disclosed the effort when asked about
(UNITED STATES) -- While authorized vaccines have proven safe and effective in holding the line against COVID-19, they are not 100% effective. Reports of uncommon breakthrough cases among fully vaccinated Americans, coupled with the delta variant tearing through the country, threaten to undermine the... Read More.
(NEW YORK) -- A Centers for Disease Control and Prevention panel once again warned consumers this week not to use commercial antibody tests to check whether or not they are immune to COVID-19. These tests, the panel said Thursday, are not consistent and can't be... Read More.